Product Name: DLL3 Antibody
Species Reactivity: Human
Tested Applications: IF, IHC-P, WB
Applications: For WB starting dilution is: 1:1000For IHC-P starting dilution is: 1:10~50For IF starting dilution is: 1:10~50
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 65 kDa
Immunogen: This DLL3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 545-573 amino acids from the C-terminal region of human DLL3.
Host Species: Rabbit
Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.
Physical State: Liquid
CAS NO.: 30544-47-9
Product: Etofenamate
Buffer: Supplied in PBS with 0.09% (W/V) sodium azide.
Concentration: 0.5 mg/ml
Storage Conditions: Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: Delta-like protein 3, Drosophila Delta homolog 3, Delta3, DLL3
Accession NO.: Q9NYJ7
Protein Ino: 12229810
Official Symbol: DLL3
Geneid: 10683
Background: This gene encodes a member of the delta protein ligandfamily. This family functions as Notch ligands that arecharacterized by a DSL domain, EGF repeats, and a transmembranedomain. Mutations in this gene cause autosomal recessivespondylocostal dysostosis 1. Two transcript variants encodingdistinct isoforms have been identified for this gene. [provided byRefSeq].
PubMed ID:http://aac.asm.org/content/38/9/2054.abstract
